Evidence map›Paper›PMID 35140093›Full record

ArticleBMJ case reports2022

Cavernous haemangioma of anterior mitral valve leaflet: diagnostic utility of 3D echocardiography.

Nicholas Bayfield, Liam Bibo, Edward Wang, Jurgen Passage

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nicholas BayfieldDepartment of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia ngbayfield@live.com.au.ORCID http://orcid.org/0000-0002-5860-8153
Liam BiboDepartment of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Edward WangDepartment of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.ORCID http://orcid.org/0000-0003-0810-7761
Jurgen PassageDepartment of Cardiothoracic Surgery, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Sir Charles Gairdner Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitral valve (MV) haemangiomas are rare primary cardiac tumours which may cause progressive cardiac failure as well as sudden death. We present a case of a 44-year-old woman referred for surgical correction of symptomatic severe mitral regurgitation. Preoperative two-dimensional transthoracic and transoesophageal echocardiography (TOE) were reported as demonstrating complex bi-leaflet prolapse causing severe mitral regurgitation. The patient was listed for MV surgery. Only on preoperative CT coronary angiogram was a filling defect noted, leading to suspicion of a cardiac tumour. Prior to skin incision, three-dimensional (3D) TOE revealed a 2×3 cm mass attached to the anterior leaflet of the MV. The tumour was subsequently resected, and the MV replaced. Postoperative histopathology confirmed a large cavernous haemangioma of the anterior MV leaflet. This case highlights a rare cause of severe mitral regurgitation and demonstrates the utility of 3D TOE as an adjunctive modality in confirming the suspected diagnosis of a cardiac tumour.

Indexed as

Echocardiography, Three-DimensionalHemangioma, CavernousMitral Valve InsufficiencyMitral Valve ProlapseAdultEchocardiography, TransesophagealFemaleHumansMitral Valvecancer - see oncologycardiothoracic surgeryultrasonographyvalvar diseases

Identifiers

PMID35140093
PMCPMC8830166
OpenAlexW4210934766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.